Mark S. Blumenkranz is Director of IVERIC bio, Inc.. Currently has a direct ownership of 0 shares of ISEE, which is worth approximately $0. The most recent transaction as insider was on Jul 11, 2023, when has been sold 32,088 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Mark S. Blumenkranz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 11 2023
SELL
Sale (or disposition) back to the issuer
-
32,088 Reduced 100.0%
0 Common Stock
May 11 2023
BUY
Exercise of conversion of derivative security
-
14,588 Added 31.25%
32,088 Common Stock
Jul 15 2022
BUY
Exercise of conversion of derivative security
-
5,000 Added 22.22%
17,500 Common Stock
May 11 2022
BUY
Exercise of conversion of derivative security
-
7,500 Added 37.5%
12,500 Common Stock
Jul 15 2021
BUY
Exercise of conversion of derivative security
-
5,000 Added 50.0%
5,000 Common Stock

Also insider at

ONEM
1Life Healthcare Inc Healthcare
KALA
Kala Pharmaceuticals, Inc. Healthcare
MSB

Mark S. Blumenkranz

Director
Parsippany, NJ

Track Institutional and Insider Activities on ISEE

Follow IVERIC bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ISEE shares.

Notify only if

Insider Trading

Get notified when an Iveric Bio, Inc. insider buys or sells ISEE shares.

Notify only if

News

Receive news related to IVERIC bio, Inc.

Track Activities on ISEE